Drugs / B-3E07
last change Apr 2026 re-read 2 minutes ago

B-3E07

Investigated by
Syneos Health · Yifan Pharmaceutical (Shanghai) Co., Ltd.

Trials 1 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT07497503 Apr → Sep 2026 expected Syneos Health Recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as B-3E07 ClinicalTrials.gov intervention name — accepted as the source's own label NCT07497503
Route Subcutaneous “B-3E07 will be administered as SC injection.” NCT07497503